August « 2015 « Science and Enterprise

Sanofi, Google to Partner on Diabetes Care, Devices

By Alan, on August 31st, 2015%

Prototype contact lens with sensors to detect and measure glucose levels in tears (Google Inc.)

31 August 2015. The pharmaceutical company Sanofi is collaborating with Google’s life sciences teams to develop technologies for improving the care of people with diabetes. Financial and intellectual property details of the partnership were not disclosed.

Diabetes is . . . → Read More: Sanofi, Google to Partner on Diabetes Care, Devices

In-Heart Pacemaker Benefits Shown in Clinical Trial

By Alan, on August 31st, 2015%

Nanostim device (St. Jude Medical)

31 August 2015. First reports from a clinical trial of a heart pacemaker placed inside the heart without wires shows after six months the device maintained effective pacing of patients’ hearts and worked without serious adverse effects in a vast majority of cases. Results of the trial testing . . . → Read More: In-Heart Pacemaker Benefits Shown in Clinical Trial

Simple Scaffold Developed for Synthetic Heart Tissue

By Alan, on August 28th, 2015%

Milica Radisic (University of Toronto)

28 August 2015. Engineers at University of Toronto in Canada designed a biocompatible mesh framework that makes it easier to grow synthetic heart muscle tissue for research and medical use. The team led by chemical engineering professor Milica Radisic published its findings today in the journal Science Advances.

FDA Proposes Guidance, Rule on Biosimilar Naming

By Alan, on August 28th, 2015%

(angelsalamag054, Pixabay)

28 August 2015. The U.S. Food and Drug Administration proposed new guidance yesterday to provide a common, nonproprietary naming system for generic forms of biologic treatments, known as biosimilars. The agency also proposed a rule applying the system to six biologics and biosimilars already approved, announced with the guidance in a . . . → Read More: FDA Proposes Guidance, Rule on Biosimilar Naming

Allied-Bristol Licensing Immunotherapy Technology

By Alan, on August 27th, 2015%

David Spiegel (Yale University)

27 August 2015. Allied-Bristol Life Sciences, a joint venture of science commercialization company Allied Minds and Bristol-Myers Squibb, is licensing a new type of synthetic chemistry technology from Yale University that can stimulate the immune system to treat cancer. Financial details of the licensing agreement were not disclosed.

The . . . → Read More: Allied-Bristol Licensing Immunotherapy Technology

Trial Shows Response to Antibody Treating Multiple Myeloma

By Alan, on August 27th, 2015%

Multiple myeloma characterized by immature plasma cells (National Library of Medicine, NIH)

27 August 2015. An early-stage clinical trial shows some patients receiving an engineered antibody to attack multiple myeloma cancer cells experienced at least a partial remission of their disease. Results of the study, led by oncologist Paul Richardson of Dana-Farber Cancer . . . → Read More: Trial Shows Response to Antibody Treating Multiple Myeloma

Pharma, Research Group Partner on Meningitis Therapy

By Alan, on August 26th, 2015%

Cryptococcus neoformans fungus (Centers for Disease Control and Prevention)

26 August 2016. A collaboration between a company developing anti-fungal drugs and research group specializing in fungal infections aims to advance a new type of therapy for cryptococcal meningitis, a life-threatening infection affecting the brain and spinal cord. Financial details of the partnership between . . . → Read More: Pharma, Research Group Partner on Meningitis Therapy

Injected Gel Designed to Deliver Cancer Therapy

By Alan, on August 26th, 2015%

Scanning electron microscope image of a cryogel (Wyss Institute, Harvard University)

26 August 2015. Biomedical engineers at Harvard University devised a hydrogel material that when infused with tumor and immune-system cells can stimulate a therapeutic immune response in lab mice. The team from Harvard’s Wyss Institute, a biomedical engineering research center, published its . . . → Read More: Injected Gel Designed to Deliver Cancer Therapy

Alerts in Health Records Cut Delays in Cancer Diagnosis

By Alan, on August 25th, 2015%

(NEC Corporation of America with Creative Commons license)

25 August 2015. Medical researchers found electronic triggers that alert physicians when test results suggest a potential for cancer, reduce delays for patients needing follow-up care. The team led by Hardeep Singh, a professor at Baylor College of Medicine in Houston, published its findings yesterday . . . → Read More: Alerts in Health Records Cut Delays in Cancer Diagnosis

All-Purpose Hand-Held Device Checks for Vital Signs

By Alan, on August 24th, 2015%

MouthLab prototype device in use (Multisensor Diagnostics)

24 August 2015. Biomedical engineers at Johns Hopkins University in Baltimore developed a portable device that quickly returns a person’s vital health indicators in an ambulance, at an outpatient clinic, or even at home. Test results of the device, called MouthLab, led by biomedical engineering and . . . → Read More: All-Purpose Hand-Held Device Checks for Vital Signs

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise